Literature DB >> 31855003

Effects of electronic cigarette heating coil resistance and liquid nicotine concentration on user nicotine delivery, heart rate, subjective effects, puff topography, and liquid consumption.

Marzena Hiler1, Nareg Karaoghlanian1, Soha Talih1, Sarah Maloney1, Alison Breland1, Alan Shihadeh1, Thomas Eissenberg1.   

Abstract

Electronic cigarette (ECIG) nicotine delivery and other effects can be influenced by device and/or liquid characteristics and user puffing behavior. One class of ECIGs includes "sub-ohm" devices that incorporate heating coils with resistance less than 1 ohm (Ω), lower than that observed in conventional devices (e.g., ≥1.5 Ω). Relative to conventional ECIGs that operate at ≤10 W, low-resistance coils can be used to increase device power (e.g., 40-300 W). However, little is known about the individual and combined effects of ECIG power, manipulated by coil resistance, and liquid nicotine concentration on ECIG acute effects. Experienced ECIG users (N = 32) completed 4 sessions that differed by ECIG power and coil resistance (40.5 W, 0.5 Ω or 13.5 W, 1.5 Ω) and liquid nicotine concentration (3 or 8 mg/ml). In each session, participants used a 4.5-V Kanger SUBOX ECIG in a 10-puff directed and 60-min ad libitum bout. Nicotine delivery, heart rate, subjective effects, puff topography, and liquid consumption were measured. Nicotine delivery was greatest in the 8mg/ml+0.5Ω condition and lowest in the 3mg/ml+1.5Ω condition. The greatest reduction in abstinence symptoms were observed in the 8mg/ml+0.5Ω condition, although the highest ratings for satisfaction and liking were reported in the 3mg/ml+0.5Ω condition. Use of ECIGs containing 3 mg/ml nicotine liquid resulted in longer and larger puffs and increased puff frequency, though high-power/low-resistance ECIGs resulted in greater consumption of ECIG liquid. ECIG device and liquid characteristics and user puff topography should be considered simultaneously when making regulatory decisions aimed at protecting public health. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31855003      PMCID: PMC9159736          DOI: 10.1037/pha0000337

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.492


  29 in total

1.  A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Authors:  Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Electronic cigarettes: effective nicotine delivery after acute administration.

Authors:  Andrea Rae Vansickel; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2012-02-06       Impact factor: 4.244

3.  Transport phenomena governing nicotine emissions from electronic cigarettes: model formulation and experimental investigation.

Authors:  Soha Talih; Zainab Balhas; Rola Salman; Rachel El-Hage; Nareg Karaoghlanian; Ahmad El-Hellani; Mohamad Baassiri; Ezzat Jaroudi; Thomas Eissenberg; Najat Saliba; Alan Shihadeh
Journal:  Aerosol Sci Technol       Date:  2016-11-08       Impact factor: 2.908

4.  Device characteristics of long term electronic cigarette users: A follow-up study.

Authors:  Jessica Yingst; Jonathan Foulds; Susan Veldheer; Ping Du
Journal:  Addict Behav       Date:  2018-08-02       Impact factor: 3.913

5.  Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Authors:  Eric C Donny; Melissa Jones
Journal:  Drug Alcohol Depend       Date:  2009-05-15       Impact factor: 4.492

6.  Throat hit in users of the electronic cigarette: An exploratory study.

Authors:  Jean-François Etter
Journal:  Psychol Addict Behav       Date:  2015-12-14

Review 7.  Neurobiology of nicotine addiction: implications for smoking cessation treatment.

Authors:  Neal L Benowitz
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965

8.  Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips.

Authors:  Michelle Acosta; August Buchhalter; Alison Breland; Duncan Hamilton; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2004-08       Impact factor: 4.244

9.  Tobacco Use Among Middle and High School Students - United States, 2011-2016.

Authors:  Ahmed Jamal; Andrea Gentzke; S Sean Hu; Karen A Cullen; Benjamin J Apelberg; David M Homa; Brian A King
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-06-16       Impact factor: 17.586

10.  Vital Signs: Tobacco Product Use Among Middle and High School Students - United States, 2011-2018.

Authors:  Andrea S Gentzke; MeLisa Creamer; Karen A Cullen; Bridget K Ambrose; Gordon Willis; Ahmed Jamal; Brian A King
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-02-15       Impact factor: 17.586

View more
  14 in total

Review 1.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

2.  Variable Voltage, Tank-Style ENDS Do Not Always Deliver Nicotine.

Authors:  Alisha Eversole; Sarah Maloney; Soha Talih; Rola Salman; Nareg Karaoghlanian; Thokozeni Lipato; Thomas Eissenberg; Alison Breland
Journal:  Tob Regul Sci       Date:  2020-11

3.  First E-Cigarette Flavor and Device Type Used: Associations With Vaping Persistence, Frequency, and Dependence in Young Adults.

Authors:  James D Sargent; Mike Stoolmiller; Hongying Dai; Jessica L Barrington-Trimis; Rob McConnell; Janet Audrain-McGovern; Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2022-02-14       Impact factor: 5.825

4.  e-Cigarette Vapour Condensate Reduces Viability and Impairs Function of Human Osteoblasts, in Part, via a Nicotine Dependent Mechanism.

Authors:  Thomas Nicholson; Lauren Davis; Edward T Davis; Matthew Newton Ede; Aaron Scott; Simon W Jones
Journal:  Toxics       Date:  2022-08-28

5.  The Role of Nicotine and Flavor in the Abuse Potential and Appeal of Electronic Cigarettes for Adult Current and Former Cigarette and Electronic Cigarette Users: A Systematic Review.

Authors:  Mari S Gades; Aleksandra Alcheva; Amy L Riegelman; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

6.  The interaction of nicotine concentration and device power on electronic nicotine delivery system (ENDS) abuse liability among exclusive ENDS users and dual users of ENDS and combustible cigarettes.

Authors:  Cosima Hoetger; Rose S Bono; Augustus M White; Andrew J Barnes; Caroline O Cobb
Journal:  Exp Clin Psychopharmacol       Date:  2021-10-14       Impact factor: 3.492

7.  Laboratory Determination of Gravimetric Correction Factors for Real-time Area Measurements of Electronic Cigarette Aerosols.

Authors:  Sinan Sousan; Jack Pender; Dillon Streuber; Meaghan Haley; Will Shingleton; Eric Soule
Journal:  Aerosol Sci Technol       Date:  2022-03-18       Impact factor: 4.809

8.  Might limiting liquid nicotine concentration result in more toxic electronic cigarette aerosols?

Authors:  Soha Talih; Rola Salman; Rachel El-Hage; Ebrahim Karam; Nareg Karaoghlanian; Ahmad El-Hellani; Najat Saliba; Thomas Eissenberg; Alan Shihadeh
Journal:  Tob Control       Date:  2020-06-10       Impact factor: 6.953

9.  Nicotine pharmacokinetics of electronic cigarettes: A pooled data analysis from the literature.

Authors:  Karin Jacobson; Javier Martinez; Sylvain Larroque; Ian W Jones; Thilo Paschke
Journal:  Toxicol Rep       Date:  2020-12-19

10.  Randomized controlled trials using electronic nicotine delivery systems as smoking cessation aids require an accurate, empirically-based understanding of the nicotine delivery profile of the products under study.

Authors:  Sarah F Maloney; Cosima Hoetger; Alyssa K Rudy; Alisha Eversole; Ashlee N Sawyer; Caroline O Cobb; Andrew J Barnes; Alison Breland; Thomas Eissenberg
Journal:  J Public Health Emerg       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.